Comprehensive evaluation of ESR2 variation and ovarian cancer risk.
Leigh Pearce C, Near AM, Butler JL, Van Den Berg D, Bretsky P, Conti DV, Stram DO, Pike MC, Hirschhorn JN, Wu AH.
Leigh Pearce C, et al. Among authors: wu ah.
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):393-6. doi: 10.1158/1055-9965.EPI-07-2512.
Cancer Epidemiol Biomarkers Prev. 2008.
PMID: 18268123